Expression and significance of IL-10 mRNA in children patients with mycoplasma pneumoniae pneumonia
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
- Issue:
- 3
- DOI:
- 10.3760/cma.j.issn.1008-6706.2011.03.001
- Key Word:
- 肺炎,支原体;白细胞介素10;聚合酶链反应;Pneumoniae,mycoplasma;Interleukin-10;Polymerase chain reaction
Abstract： Objective To investigate the expression and significance of interkeulin 10 (IL-10)in children patients with mycoplasma pneumoniae pneumonia(MP). Methods Twenty-six children patients with MP( MP group)and20 health control( contrl group)were sequentially enrolled in this study. The production of IL-10 mRNA was measured by fluorescent quantitative polymerase chain reaction. Results Expression of IL-10 mRNA in MP group (33 893.22±5 207.60) copy/μg was significantly lower than that in control group(59 341.92 ±6 712.98) copy/μg(t = - 14. 49, P ＜ 0. 01 ). Expression of IL-10 mRNA in heavy degree MP group was significantly lower than that of mild degree MP group ( t= - 2. 20, P ＜ 0. 05 ). Conclusion The expression of IL-10 was low, and played an important role in the development of patients with MP.
- [1]刘莉.C-反应蛋白在重症肺炎支原体肺炎中的意义[J].2006,(24).
- [2]吴昱东,黄东生.肺炎支原体肺炎患儿血清心肌酶临床分析[J].2010,(12).
- [3]任大宾,孙仁宇.白介素-10的抗炎功能及其分子机制[J].2005,(3).
- [4].NF-κB在支气管哮喘中的作用及临床意义[J].2005,(11).
- [5]汪咪珍.支原体肺炎病原体检测方法比较[J].2010,(11).
- [6]段晓燕,于晓晴,张开元.肺炎支原体肺炎患儿血清TNF-αIL-6 IL-10的水平检测及其临床意义[J].2007,(11).
- [7]周岳年.肺炎支原体肺炎患儿血清细胞因子及高敏C反应蛋白、免疫球蛋白的检测及其临床意义[J].2010,(4).
- [8]徐利,张庆侠,杨征,等.儿童肺炎支原体感染血清免疫球蛋白水平、红细胞免疫功能、T淋巴细胞亚群变化的动态观察[J].2009,(12).
- [9]蔡建敏,陈同辛,王振海,等.肺炎支原体肺炎患儿血清白细胞介素-10、转化生长因子-β1检测的意义[J].2007,(4).
- [10]邓素娟,朱美华.儿童重症肺炎支原体肺炎炎性相关因素的变化及临床意义[J].2010,(7).
- [11]Tamura A,Fukaya T,Yura K,etc.Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children.[J].2008,57(3).
- [12]胡亚美.实用儿科学[M].1993.
- [13]Horowitz S,Schlaeffer F,Horovitz O,etc.Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients.[J].1996,63(5).
- [14]Aggarwal BB,Garg A.Nuclear transcription factor-kappaB as a target for cancer drug development.[J].2002,16(6).